LIPOSYN III 10% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Liposyn Iii 10%, and when can generic versions of Liposyn Iii 10% launch?
Liposyn Iii 10% is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in LIPOSYN III 10% is soybean oil. There are thirteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIPOSYN III 10%?
- What are the global sales for LIPOSYN III 10%?
- What is Average Wholesale Price for LIPOSYN III 10%?
Summary for LIPOSYN III 10%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 4 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LIPOSYN III 10% at DailyMed |
![LIPOSYN III 10% drug patent expirations Drug patent expirations by year for LIPOSYN III 10%](/p/graph/s/t/LIPOSYN_III_10%-patent-expirations.png)
Recent Clinical Trials for LIPOSYN III 10%
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Cleveland Clinic | Early Phase 1 |
Pennington Biomedical Research Center | Early Phase 1 |
The University of Texas Health Science Center at San Antonio | N/A |
US Patents and Regulatory Information for LIPOSYN III 10%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | LIPOSYN III 10% | soybean oil | INJECTABLE;INJECTION | 018969-001 | Sep 24, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |